Study Summary
This trial is testing a new cancer treatment combining two existing therapies in the hopes of creating a more favorable immunologic response in patients with a specific type of head and neck cancer.
- Head and Neck Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: 12 weeks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Group 1
1 of 2
Group 2
1 of 2
Experimental Treatment
20 Total Participants · 2 Treatment Groups
Primary Treatment: Pembrolizumab · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 12 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What potential harms may arise from Pembrolizumab usage?
"The low amount of available data on pembrolizumab's efficacy and safety resulted in a score of 1 being assigned to the drug." - Anonymous Online Contributor
How many human participants are being observed for this clinical investigation?
"Affirmative, the available data on clinicaltrials.gov reveals that this research endeavor is currently recruiting participants. Initially posted on October 20th 2017, it seeks to enrol 20 patients from a single location." - Anonymous Online Contributor
Has this research project started accepting participants yet?
"This clinical trial, which was published in October 2017, is still actively seeking participants. The details have been recently updated on March 31st 2022 according to the information provided by clinicaltrials.gov." - Anonymous Online Contributor
What evidence exists to support the efficacy of Pembrolizumab?
"Presently, 1151 trials are conducted regarding the effectiveness of Pembrolizumab. Out those active studies, 175 have moved past Phase 2 and into the third phase of investigation. These medical experiments can be found across 39737 different locations globally with a concentration in Cleveland, Ohio." - Anonymous Online Contributor
What medical applications commonly utilize Pembrolizumab?
"As a therapeutic option, pembrolizumab can be used to address bursitis as well as other ailments such as melanoma, metastatic cutaneous squamous cell carcinoma, and cardiovascular disorders." - Anonymous Online Contributor
Is this research an unprecedented discovery?
"To date, 1151 clinical trials concerning the effectiveness of pembrolizumab are active across 3313 cities and 75 nations. Abbott first initiated an experiment with 15480 participants in 2005, leading to its Phase 4 drug approval stage; yet since then 982 more studies have been completed." - Anonymous Online Contributor